Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide NIH notice announces an update to terminology, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.6%
    Check dated 2026-10-25T14:24:58.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, while the clinical study record information remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-18T14:30:48.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The website revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T14:40:01.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The study record now names Adrienne G. Waks instead of Otto Metzger, MD, and shows a new 18th version submitted on September 10, 2026, with updates to study status, sponsor/collaborators, contacts/locations, and adverse events. The latest update was posted October 2, 2026.
    Difference
    0.7%
    Check dated 2026-10-04T16:55:15.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed from the history.
    Difference
    0.1%
    Check dated 2026-09-20T19:34:03.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history, and the previous revision v3.6.5 was removed.
    Difference
    0.1%
    Check dated 2026-08-30T18:58:50.000Z thumbnail image

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.